Labtech
Business area Labtech
Your Labtech distributor in 29 European countries
The subsidiaries in the Labtech business area cover the market of 29 European countries and provide products, solutions and services in diagnostics, biomedical research and laboratory analysis.
The Labtech business area works closely with customers and suppliers through highly developed local sales and service organisations. The companies have strong market positions and highly qualified personnel.
The business area offers products and solutions, including equipment, consumables and reagents, used to diagnose diseases, conduct research or perform analysis.
Our companies also provide training and technical service to facilitate effective equipment use. As a distributor, we can respond quickly to a changing market and deliver customer-tailored solutions.
Join AddLife
Are you looking for a distributor across Europe?
We are always looking for new premium suppliers for our subsidiaries covering 29 European countries. Please fill in the match-making form and if there is a match, we will help you find the right contact person at AddLife.

Labtech´s strengths
- Dedicated and highly qualified employees with many years of experience in the segment
- High quality products, service, training programmes and advisory services
- Long term collaboration with leading suppliers and exclusive distribution rights
- Strong technical service organisation with local support
Labtech 2021 in figures
Net sales: 4,373 SEKm
EBITA: 977 SEKm
Employees: 765
Share of net sales: 55%
Net sales by market Labtech 2021
News from our Labtech subsidiaries

Biomedica Italia Srl and MBA Italia Srl have merged into Biomedica Italia Srl, becoming a single entity for the distribution of surgical specialties within the AddLife group. This new company is stronger and more competitive, offering opportunities for future growth.
New solutions for sepsis diagnostics have emerged alongside the more conventional methods. As a result, preparing a sepsis diagnosis, identifying the pathogen and determining the antibiotic susceptibility are quicker and more accurate and effective.
Implementing the requirements of the new EU Regulations improves patient safety and clarifies the responsibilities of the various operators in the distributor chain. Triolab has prepared for the regulatory reform for a long time.
Sepsis is a potentially life-threatening condition caused by the body‘s response to an infection. Prompt diagnosis, intervention, and risk assessment are essential in caring for sepsis.
Contact us!
We are happy to help with questions regarding the business area Labtech


